Cheryl Xu
Net worth: 5 259 $ as of 29/09/2026
Net worth: 5 259 $ as of 29/09/2026
Cheryl Xu is currently Director at 60 Degrees Pharmaceuticals, Inc. since 2023.
Formerly, Ms. Xu was Director-International Finance at Pharmacia Corp.
and Vice President-Public Policy & Government Affairs at Biogen, Inc. Ms. Xu earned an MBA from the University of Washington and completed undergraduate studies at Peking University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/07/2026 | 3,954 ( 0.11% ) | 5 259 $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Director/Board Member | 10/07/2023 |
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 28/02/2023 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Director of Finance/CFO | 27/03/2013 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for infectious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions